Whitehead Sara J, Kilmarx Peter H, Blanchard Kelly, Manopaiboon Chomnad, Chaikummao Supaporn, Friedland Barbara, Achalapong Jullapong, Wankrairoj Mayuree, Mock Philip, Thanprasertsuk Sombat, Tappero Jordan W
National Center for HIV, Viral Hepatitis, STDs, and Tuberculosis Prevention (proposed), Centers for Disease Control and Prevention, Atlanta, USA.
AIDS. 2006 Nov 14;20(17):2141-8. doi: 10.1097/QAD.0b013e32801086c9.
To evaluate the acceptability of candidate microbicide Carraguard among couples participating in a safety trial.
A 6-month randomized, placebo-controlled trial was conducted in sexually active, low-risk couples in Thailand.
Couples who were monogamous, HIV uninfected, and not regular condom users were enrolled. Acceptability data were collected through structured questionnaires at repeated intervals. At the closing study visit, participants were asked questions about hypothetical product characteristics and future use. Compliance with gel use was assessed by questionnaires, coital diaries, and tracking of used and unused applicators.
Among 55 enrolled couples, follow up and adherence with gel use were high and sustained, with 80% of women using gel in over 95% of vaginal sex acts. Because acceptability results from Carraguard and placebo arms were similar, they were combined for this analysis. Overall, 92% of women and 83% of men liked the gel somewhat or very much; 66% of women and 72% of men reported increased sexual pleasure with gel use; and 55% of women and 62% of men reported increased frequency of intercourse. Only 15% of women but 43% of men thought that gel could be used without the man knowing. Although men and women had similar views overall, concordance within couples was low, with no kappa coefficients above 0.31.
Carraguard gel use was acceptable to low-risk couples in northern Thailand. Reported associations between gel use and increased sexual pleasure and frequency suggest a potential to market microbicide products for both disease prevention and enhancement of pleasure.
评估候选杀微生物剂角叉菜胶避孕套(Carraguard)在参与安全性试验的夫妇中的可接受性。
在泰国性活跃的低风险夫妇中进行了一项为期6个月的随机、安慰剂对照试验。
招募一夫一妻制、未感染艾滋病毒且不经常使用避孕套的夫妇。通过定期的结构化问卷收集可接受性数据。在研究结束访视时,询问参与者关于假设的产品特性和未来使用的问题。通过问卷、性交日记以及对已使用和未使用的涂抹器的追踪来评估凝胶使用的依从性。
在55对入组夫妇中,对凝胶使用的随访和依从性很高且持续,80%的女性在超过95%的阴道性行为中使用了凝胶。由于Carraguard组和安慰剂组的可接受性结果相似,因此将它们合并进行此分析。总体而言,92%的女性和83%的男性有点喜欢或非常喜欢该凝胶;66%的女性和72%的男性报告使用凝胶后性快感增加;55%的女性和62%的男性报告性交频率增加。只有15%的女性但43%的男性认为凝胶可以在男性不知情的情况下使用。虽然男性和女性总体上有相似的看法,但夫妇内部的一致性较低,卡帕系数均未超过0.31。
在泰国北部,低风险夫妇可以接受使用Carraguard凝胶。报告的凝胶使用与性快感增加和性交频率增加之间的关联表明,杀微生物剂产品在疾病预防和增强快感方面都有潜在的市场。